Literature DB >> 17360963

The tumor-necrosis-factor-associated periodic syndrome, the brain, and tumor-necrosis-factor-alpha antagonists.

B Wildemann1, G Rudofsky, B Kress, S Jarius, F Konig, V Schwenger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17360963     DOI： 10.1212/01.wnl.0000260226.21010.2b

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  5 in total

Review 1.  [Neuroimmunology and rheumatology: overlap and differential diagnoses].

Authors:  C Trebst; T Kümpfel
Journal:  Nervenarzt       Date:  2018-10       Impact factor: 1.214

2.  Role of tumour necrosis factor (TNF)-α and TNFRSF1A R92Q mutation in the pathogenesis of TNF receptor-associated periodic syndrome and multiple sclerosis.

Authors:  A Caminero; M Comabella; X Montalban
Journal:  Clin Exp Immunol       Date:  2011-12       Impact factor: 4.330

Review 3.  Key facts and hot spots on tumor necrosis factor receptor-associated periodic syndrome.

Authors:  Donato Rigante; Giuseppe Lopalco; Antonio Vitale; Orso Maria Lucherini; Caterina De Clemente; Francesco Caso; Giacomo Emmi; Luisa Costa; Elena Silvestri; Laura Andreozzi; Florenzo Iannone; Mauro Galeazzi; Luca Cantarini
Journal:  Clin Rheumatol       Date:  2014-06-17       Impact factor: 2.980

4.  Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci.

Authors:  Philip L De Jager; Xiaoming Jia; Joanne Wang; Paul I W de Bakker; Linda Ottoboni; Neelum T Aggarwal; Laura Piccio; Soumya Raychaudhuri; Dong Tran; Cristin Aubin; Rebeccah Briskin; Susan Romano; Sergio E Baranzini; Jacob L McCauley; Margaret A Pericak-Vance; Jonathan L Haines; Rachel A Gibson; Yvonne Naeglin; Bernard Uitdehaag; Paul M Matthews; Ludwig Kappos; Chris Polman; Wendy L McArdle; David P Strachan; Denis Evans; Anne H Cross; Mark J Daly; Alastair Compston; Stephen J Sawcer; Howard L Weiner; Stephen L Hauser; David A Hafler; Jorge R Oksenberg
Journal:  Nat Genet       Date:  2009-06-14       Impact factor: 38.330

5.  Neurological phenotypes in patients with NLRP3-, MEFV-, and TNFRSF1A low-penetrance variants.

Authors:  Elisabeth Mulazzani; Danny Wagner; Joachim Havla; Miriam Schlüter; Ingrid Meinl; Lisa-Ann Gerdes; Tania Kümpfel
Journal:  J Neuroinflammation       Date:  2020-06-20       Impact factor: 8.322
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.